INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 01, 2021 |
Director
Trans History: 65
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 2,558 | $575.00 | 891 |
| May 11, 2020 |
Director
Trans History: 320
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 250 | $575.00 | 2,150 |
| May 11, 2020 |
Director
Trans History: 320
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 300 | $575.00 | 3,400 |
| May 11, 2020 |
Director
Trans History: 320
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 300 | $575.00 | 8,700 |
| Aug 02, 2021 |
Director
Trans History: 524
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5 | $575.24 | 23,469 |
| May 21, 2020 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 2,606 | $575.34 | 308,738 |
| Aug 14, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Open market or private sale of non-derivative or derivative security | 700 | $575.47 | 21,583 |
| May 12, 2020 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 2,196 | $575.48 | 476,865 |
| Nov 02, 2015 |
Director, President Regeneron Laboratori
Trans History: 617
|
Director, President Regeneron Laboratori | Form 4 | Open market or private sale of non-derivative or derivative security | 2,441 | $575.64 | 548,377 |
| May 21, 2020 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 206 | $576.47 | 308,532 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.